Real-world usage, effectiveness, and microbiological features of ceftazidime-avibactam in clinical practice in China.

Saved in:
Bibliographic Details
Title: Real-world usage, effectiveness, and microbiological features of ceftazidime-avibactam in clinical practice in China.
Authors: Qin X; Institute of Antibiotics, Huashan Hospital, Fudan University, Shanghai, China., Xiang T; Department of Infectious Diseases, The First Affiliated Hospital of Nanchang University, Nanchang, China., Zhang X; Department of Pulmonary and Critical Care Medicine, Henan Provincial People's Hospital, Zhengzhou, China., Ma X; Department of Infectious Diseases, Beijing Tsinghua Changgung Hospital, Beijing, China., Zhao W; Department of Infectious Diseases, The First Affiliated Hospital of Soochow University, Suzhou, China., Yu Y; Department of Liver Diseases and Infectious Diseases, Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, Hangzhou, China., Zhao C; Department of Infectious Diseases, The Third Hospital of Hebei Medical University, Shijiazhuang, China., Gao L; Department of Neurosurgery, Shanghai Tenth People's Hospital, Shanghai, China., Li L; Department of Critical Care Medicine, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, China., Wang T; Department of Hematology, The Affiliated Hospital of Ningbo University Medical College, Ningbo, China., Pang C; Department of Infectious Diseases, Tianjin Medical University General Hospital, Heping, China., Zhao X; Institute of Antibiotics, Huashan Hospital, Fudan University, Shanghai, China., Han R; Institute of Antibiotics, Huashan Hospital, Fudan University, Shanghai, China., Cao F; China Medical, Pfizer Inc, Beijing, China., Su M; China Medical, Pfizer Inc, Shanghai, China., Lu J; China Medical, Pfizer Inc, Shanghai, China., Xu W; China Medical, Pfizer Inc, Beijing, China., Yin S; China Medical, Pfizer Inc, Shanghai, China., Lu D; China Medical, Pfizer Inc, Shanghai, China., Yang X; China Medical, Pfizer Inc, Beijing, China., Wang M; Institute of Antibiotics, Huashan Hospital, Fudan University, Shanghai, China.
Source: Frontiers in cellular and infection microbiology [Front Cell Infect Microbiol] 2026 Jan 27; Vol. 15, pp. 1663392. Date of Electronic Publication: 2026 Jan 27 (Print Publication: 2025).
Publication Type: Journal Article; Multicenter Study; Observational Study
Journal Info: Publisher: Frontiers Media SA Country of Publication: Switzerland NLM ID: 101585359 Publication Model: eCollection Cited Medium: Internet ISSN: 2235-2988 (Electronic) Linking ISSN: 22352988 NLM ISO Abbreviation: Front Cell Infect Microbiol Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:2235-2988
DOI:10.3389/fcimb.2025.1663392